Perspective Therapeutics, Inc. (CATX) vs Profound Medical (PROF)

Perspective Therapeutics, Inc. and Profound Medical are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $267.1M against $230.5M — 1.2× the size. Profound Medical grew revenue faster over the last twelve months: 61.2% against −66.9%. Profound Medical has the higher net margin (−171.6% vs −28,468.0%) and the lower return on invested capital (−137.8% vs −88.4%). Across the 18 metrics below, Perspective Therapeutics, Inc. leads on 9 and Profound Medical on 9.

Valuation

Metric CATX PROF Medical Devices median
P/E n/m n/m 23.22
P/S 640.13 11.45 2.34
P/B 0.81 4.39 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 64.74 9.91 2.24
Earnings yield (61.15%) (16.31%) (10.09%)
Free cash flow yield (46.29%) (16.82%) (8.47%)

Profitability

Metric CATX PROF Medical Devices median
Gross margin 100.00% 71.79% 56.01%
Operating margin (30,619.07%) (185.31%) (15.03%)
Net margin (28,467.97%) (171.56%) (20.40%)
Free cash flow margin (29,630.07%) (189.15%) (7.24%)
Return on equity (39.50%) (73.53%) (15.32%)
Return on assets (33.14%) (58.44%) (19.72%)
Return on invested capital (88.41%) (137.78%) (10.33%)

Growth

Metric CATX PROF Medical Devices median
Revenue growth (TTM) (66.88%) 61.20% 8.80%
EPS growth (last fiscal year) (13.82%) (25.89%) 29.03%
Revenue growth, 5-year CAGR (38.04%) 17.12% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CATX PROF Medical Devices median
Debt to equity 0.00 0.09 0.07
Current ratio 6.61 6.46 2.50
Net debt to EBITDA 1.27 1.36 0.49

Dividend

Metric CATX PROF Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric CATX PROF Medical Devices median
Market cap 267.12m 230.50m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack